Market expert Raja Venkatraman from NeoTrader has recommended five stocks for trading on 25 September 2026, as Indian equities showed continued weakness with selling pressure intensifying across key sectors. According to latest market data, Indian markets extended their sharp gap-down opening into the mid-session, with the Sensex plunging 813 points or 1.09% to 74,015.05 and the Nifty 50 slipping 265 points or 1.13% to 23,181.80 by 1:18 pm. The India VIX declined nearly 3% to 10.9, indicating easing volatility, while the rupee firmed to 95.59 against the dollar. Selling pressure intensified across financials, metals, and insurance counters, dragging benchmarks lower with only four Nifty stocks—Cipla, SBI Life, Bharat Electronics, and NTPC—trading in positive territory. Elevated crude prices near $91 and US Treasury yields above 5% further weighed on sentiment, while geopolitical tensions kept risk appetite subdued.
CAPLIPOINT is recommended at ₹2,867.40 with a buy above ₹2,870 and stop loss at ₹2,750 targeting ₹3,080 within 2 months. As reported by NeoTrader, Caplin Point Laboratories Limited is an established Indian pharmaceutical company, specializing in the development, manufacturing, and export of generic and branded formulations. After some consolidation seen since last few weeks, the last two sessions have seen a strong recovery that has led to some value area supports around the Kumo cloud that is holding back the decline. In the process, we are noticing that some buying interest also develop. Also, the services sector is seen reviving and in the last month has performed well. With the Average Directional Index after a pullback is seen crossing important thresholds, it can lead to some strong upward move in the coming weeks. Key metrics include P/E ratio of 51.75, 52-week high of ₹2,874, and volume of 1.24 million shares. Technical analysis indicates support at ₹2,500 and resistance at ₹2,300.
CHALET is recommended at ₹894.90 with a buy above ₹895 and stop loss at ₹845 targeting ₹980 within 2 months. According to NeoTrader, CHALET is an owner, developer, asset manager, and operator of high-end hotels, commercial spaces, and residential real estate in India. Since March 2026, the steady upward traction in this counter after some profit booking is seen helping the prices move higher, forming higher lows and the strong action with volumes seen this week highlights steady buying at despite the market situation. A move from the value area region around 840 zone holding good indicates that we can expect the upward drive to continue. Key metrics include P/E ratio of 35.73, 52-week high of ₹1,029.95, and volume of 129.56K shares. Technical analysis indicates support at ₹800 and resistance at ₹1,030.
IKS is recommended at a current market price of ₹1,937.80 with a buy above ₹1,940 and stop loss at ₹1,865 targeting ₹2,100 within 2 months. As reported by NeoTrader, Inventurus Knowledge Solutions Ltd. (operating as IKS Health) is a technology-enabled healthcare solutions provider and care enablement platform founded in 2006. After some consolidation seen since last few weeks, the last two sessions have seen a strong recovery that has led to some value area supports around the Kumo cloud that is holding back the decline. The services sector is seen reviving with strong performance in the last month, and the Average Directional Index after a pullback is crossing important thresholds. Key metrics include P/E ratio of 53.63, 52-week high of ₹1,933.75, and volume of 1.01 million shares. Technical analysis indicates support at ₹1,700 and resistance at ₹2,300.
MOTILALOFS is recommended at ₹1,042.50 with a buy above ₹1,045 and stop loss at ₹990 targeting ₹1,165 within 2 months. As reported by NeoTrader, Motilal Oswal Financial Services Limited (MOFSL) is a prominent diversified financial services group in India, headquartered in Mumbai. The steady upward traction in this counter after some profit booking is seen helping the prices move higher, forming higher lows with strong action with volumes seen on Monday. A move from the value area region around 970-980 zone holding good indicates that we can expect the upward drive to continue. Key metrics include P/E ratio of 27.87, 52-week high of ₹1,121.95, and volume of 1.61 million shares. Technical analysis indicates support at ₹670 and resistance at ₹900.
VIJAYA is recommended at ₹1,570.70 with a buy above ₹1,575 and stop loss at ₹1,429 targeting ₹1,725 within 2 months. As reported by NeoTrader, Vijaya Diagnostic Centre Limited is a leading integrated diagnostic chain in India that offers comprehensive pathology and radiology testing services under one roof. The recent recovery after dips into the strong support region around the Tenkan Sen and Kijun Sen with volumes signal a potential revival. The sustained consolidation and then an upmove looks to be a pattern that is developing, with the Chikou Span getting into the clear the trends are showing some promise of upside. Key metrics include P/E ratio of 84.23, 52-week high of ₹1,593.60, and volume of 209.30K shares. Technical analysis indicates support at ₹1,470 and resistance at ₹1,825.
According to NeoTrader, the markets are continuing to showcase hesitation and are slipping at the slightest hint of negative newsflow, with trends remaining pressured to the downside as we await some clarity. Trends remained in distress as the higher levels were used to supply on a continuous basis, with the markets not behaving as expected and the trends ahead continuing to remain in a challenging mode. Despite the large-scale volatility, the trends have been quite active in certain stocks, making it a very stock-specific movement. With the wavering global news continuing to curb the trends to proceed higher clearly indicating that there is a need to adopt a restrained market approach. The Nifty recovery as it heads into the monthly expiry is giving a negative handover to October woods but the rally is seen heading into resistance. A continued move beyond the median line will need a closing above the median line without which further upside is not possible. The Put Call Ratio (PCR) has neared 1 in Nifty and Bank Nifty highlighting some strong Put writing as a bottoming approach is being attempted by the bullish camp. With the lack of clarity on trends continue, we need to tread the road ahead carefully.
